Clinical Trial Update: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 trial in children with nonalcoholic steatohepatitis evaluating the efficacy and tolerability of DHA, choline, and vitamin E has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver
• Liver Fibrosis
• Metabolic Syndrome
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis
• Obesity

Drugs mentioned

• Choline (Choline)
• DHA (Docosahexaenoic acid)
• Vitamin E (tocopherol)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Fatty Liver, Liver Fibrosis | Phase 3 | Status: COMPLETED